nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—CYP2C18—Omeprazole—Barrett's esophagus	0.31	0.369	CbGbCtD
Methadone—CYP2C19—Esomeprazole—Barrett's esophagus	0.106	0.126	CbGbCtD
Methadone—CYP2C8—Omeprazole—Barrett's esophagus	0.0744	0.0884	CbGbCtD
Methadone—CYP2C19—Omeprazole—Barrett's esophagus	0.0624	0.0741	CbGbCtD
Methadone—CYP1A2—Omeprazole—Barrett's esophagus	0.0576	0.0684	CbGbCtD
Methadone—CYP2C9—Omeprazole—Barrett's esophagus	0.0519	0.0616	CbGbCtD
Methadone—CYP3A4—Esomeprazole—Barrett's esophagus	0.0512	0.0608	CbGbCtD
Methadone—ABCB1—Omeprazole—Barrett's esophagus	0.0503	0.0598	CbGbCtD
Methadone—CYP2D6—Omeprazole—Barrett's esophagus	0.0474	0.0564	CbGbCtD
Methadone—CYP3A4—Omeprazole—Barrett's esophagus	0.0302	0.0358	CbGbCtD
Methadone—Multiple fractures—Omeprazole—Barrett's esophagus	0.00434	0.0349	CcSEcCtD
Methadone—Fracture—Omeprazole—Barrett's esophagus	0.00434	0.0349	CcSEcCtD
Methadone—Multiple fractures—Esomeprazole—Barrett's esophagus	0.00434	0.0349	CcSEcCtD
Methadone—Fracture—Esomeprazole—Barrett's esophagus	0.00434	0.0349	CcSEcCtD
Methadone—Hypomagnesaemia—Omeprazole—Barrett's esophagus	0.00397	0.0319	CcSEcCtD
Methadone—Hypomagnesaemia—Esomeprazole—Barrett's esophagus	0.00397	0.0319	CcSEcCtD
Methadone—Glossitis—Omeprazole—Barrett's esophagus	0.00273	0.022	CcSEcCtD
Methadone—Glossitis—Esomeprazole—Barrett's esophagus	0.00273	0.022	CcSEcCtD
Methadone—Lightheadedness—Omeprazole—Barrett's esophagus	0.00225	0.0182	CcSEcCtD
Methadone—Lightheadedness—Esomeprazole—Barrett's esophagus	0.00225	0.0182	CcSEcCtD
Methadone—Swelling—Esomeprazole—Barrett's esophagus	0.00207	0.0167	CcSEcCtD
Methadone—Swelling—Omeprazole—Barrett's esophagus	0.00207	0.0167	CcSEcCtD
Methadone—Visual disturbance—Esomeprazole—Barrett's esophagus	0.00193	0.0155	CcSEcCtD
Methadone—Visual disturbance—Omeprazole—Barrett's esophagus	0.00193	0.0155	CcSEcCtD
Methadone—Irritability—Omeprazole—Barrett's esophagus	0.00175	0.0141	CcSEcCtD
Methadone—Irritability—Esomeprazole—Barrett's esophagus	0.00175	0.0141	CcSEcCtD
Methadone—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00166	0.0134	CcSEcCtD
Methadone—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00166	0.0134	CcSEcCtD
Methadone—Sweating increased—Omeprazole—Barrett's esophagus	0.00154	0.0124	CcSEcCtD
Methadone—Sweating increased—Esomeprazole—Barrett's esophagus	0.00154	0.0124	CcSEcCtD
Methadone—Weight increased—Omeprazole—Barrett's esophagus	0.00144	0.0116	CcSEcCtD
Methadone—Weight increased—Esomeprazole—Barrett's esophagus	0.00144	0.0116	CcSEcCtD
Methadone—Weight decreased—Omeprazole—Barrett's esophagus	0.00143	0.0115	CcSEcCtD
Methadone—Weight decreased—Esomeprazole—Barrett's esophagus	0.00143	0.0115	CcSEcCtD
Methadone—Bradycardia—Esomeprazole—Barrett's esophagus	0.00129	0.0104	CcSEcCtD
Methadone—Bradycardia—Omeprazole—Barrett's esophagus	0.00129	0.0104	CcSEcCtD
Methadone—Hallucination—Omeprazole—Barrett's esophagus	0.00126	0.0101	CcSEcCtD
Methadone—Hallucination—Esomeprazole—Barrett's esophagus	0.00126	0.0101	CcSEcCtD
Methadone—Visual impairment—Esomeprazole—Barrett's esophagus	0.00122	0.00982	CcSEcCtD
Methadone—Visual impairment—Omeprazole—Barrett's esophagus	0.00122	0.00982	CcSEcCtD
Methadone—Flushing—Esomeprazole—Barrett's esophagus	0.00117	0.00945	CcSEcCtD
Methadone—Flushing—Omeprazole—Barrett's esophagus	0.00117	0.00945	CcSEcCtD
Methadone—Chills—Omeprazole—Barrett's esophagus	0.00114	0.00914	CcSEcCtD
Methadone—Chills—Esomeprazole—Barrett's esophagus	0.00114	0.00914	CcSEcCtD
Methadone—Muscle spasms—Esomeprazole—Barrett's esophagus	0.00106	0.00853	CcSEcCtD
Methadone—Muscle spasms—Omeprazole—Barrett's esophagus	0.00106	0.00853	CcSEcCtD
Methadone—Tremor—Esomeprazole—Barrett's esophagus	0.00103	0.00831	CcSEcCtD
Methadone—Tremor—Omeprazole—Barrett's esophagus	0.00103	0.00831	CcSEcCtD
Methadone—Agitation—Omeprazole—Barrett's esophagus	0.00101	0.00815	CcSEcCtD
Methadone—Agitation—Esomeprazole—Barrett's esophagus	0.00101	0.00815	CcSEcCtD
Methadone—Vertigo—Omeprazole—Barrett's esophagus	0.00099	0.00797	CcSEcCtD
Methadone—Vertigo—Esomeprazole—Barrett's esophagus	0.00099	0.00797	CcSEcCtD
Methadone—Palpitations—Omeprazole—Barrett's esophagus	0.000973	0.00784	CcSEcCtD
Methadone—Palpitations—Esomeprazole—Barrett's esophagus	0.000973	0.00784	CcSEcCtD
Methadone—Anxiety—Omeprazole—Barrett's esophagus	0.000934	0.00752	CcSEcCtD
Methadone—Anxiety—Esomeprazole—Barrett's esophagus	0.000934	0.00752	CcSEcCtD
Methadone—Dry mouth—Esomeprazole—Barrett's esophagus	0.000917	0.00738	CcSEcCtD
Methadone—Dry mouth—Omeprazole—Barrett's esophagus	0.000917	0.00738	CcSEcCtD
Methadone—Confusional state—Omeprazole—Barrett's esophagus	0.000906	0.0073	CcSEcCtD
Methadone—Confusional state—Esomeprazole—Barrett's esophagus	0.000906	0.0073	CcSEcCtD
Methadone—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000899	0.00724	CcSEcCtD
Methadone—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000899	0.00724	CcSEcCtD
Methadone—Shock—Esomeprazole—Barrett's esophagus	0.000884	0.00712	CcSEcCtD
Methadone—Shock—Omeprazole—Barrett's esophagus	0.000884	0.00712	CcSEcCtD
Methadone—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.00088	0.00709	CcSEcCtD
Methadone—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.00088	0.00709	CcSEcCtD
Methadone—Tachycardia—Omeprazole—Barrett's esophagus	0.000877	0.00706	CcSEcCtD
Methadone—Tachycardia—Esomeprazole—Barrett's esophagus	0.000877	0.00706	CcSEcCtD
Methadone—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000869	0.007	CcSEcCtD
Methadone—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000869	0.007	CcSEcCtD
Methadone—Anorexia—Esomeprazole—Barrett's esophagus	0.000857	0.0069	CcSEcCtD
Methadone—Anorexia—Omeprazole—Barrett's esophagus	0.000857	0.0069	CcSEcCtD
Methadone—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000827	0.0242	CbGpPWpGaD
Methadone—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000822	0.0241	CbGpPWpGaD
Methadone—CYP2C18—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000816	0.0239	CbGpPWpGaD
Methadone—Insomnia—Esomeprazole—Barrett's esophagus	0.000813	0.00655	CcSEcCtD
Methadone—Insomnia—Omeprazole—Barrett's esophagus	0.000813	0.00655	CcSEcCtD
Methadone—Somnolence—Omeprazole—Barrett's esophagus	0.000799	0.00643	CcSEcCtD
Methadone—Somnolence—Esomeprazole—Barrett's esophagus	0.000799	0.00643	CcSEcCtD
Methadone—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000781	0.00629	CcSEcCtD
Methadone—Decreased appetite—Omeprazole—Barrett's esophagus	0.000781	0.00629	CcSEcCtD
Methadone—Pain—Omeprazole—Barrett's esophagus	0.000769	0.00619	CcSEcCtD
Methadone—Constipation—Omeprazole—Barrett's esophagus	0.000769	0.00619	CcSEcCtD
Methadone—Pain—Esomeprazole—Barrett's esophagus	0.000769	0.00619	CcSEcCtD
Methadone—Constipation—Esomeprazole—Barrett's esophagus	0.000769	0.00619	CcSEcCtD
Methadone—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000741	0.00596	CcSEcCtD
Methadone—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000741	0.00596	CcSEcCtD
Methadone—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000735	0.00592	CcSEcCtD
Methadone—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000735	0.00592	CcSEcCtD
Methadone—Urticaria—Omeprazole—Barrett's esophagus	0.000714	0.00575	CcSEcCtD
Methadone—Urticaria—Esomeprazole—Barrett's esophagus	0.000714	0.00575	CcSEcCtD
Methadone—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000711	0.00572	CcSEcCtD
Methadone—Abdominal pain—Omeprazole—Barrett's esophagus	0.000711	0.00572	CcSEcCtD
Methadone—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000711	0.00572	CcSEcCtD
Methadone—Body temperature increased—Omeprazole—Barrett's esophagus	0.000711	0.00572	CcSEcCtD
Methadone—HTR3A—Ion channel transport—ATP4A—Barrett's esophagus	0.000674	0.0198	CbGpPWpGaD
Methadone—CYP2C18—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00067	0.0196	CbGpPWpGaD
Methadone—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000662	0.00533	CcSEcCtD
Methadone—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000662	0.00533	CcSEcCtD
Methadone—Asthenia—Esomeprazole—Barrett's esophagus	0.000645	0.00519	CcSEcCtD
Methadone—Asthenia—Omeprazole—Barrett's esophagus	0.000645	0.00519	CcSEcCtD
Methadone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00064	0.0188	CbGpPWpGaD
Methadone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00064	0.0188	CbGpPWpGaD
Methadone—Pruritus—Omeprazole—Barrett's esophagus	0.000636	0.00512	CcSEcCtD
Methadone—Pruritus—Esomeprazole—Barrett's esophagus	0.000636	0.00512	CcSEcCtD
Methadone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000633	0.0186	CbGpPWpGaD
Methadone—CYP19A1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000625	0.0183	CbGpPWpGaD
Methadone—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000615	0.00495	CcSEcCtD
Methadone—Diarrhoea—Omeprazole—Barrett's esophagus	0.000615	0.00495	CcSEcCtD
Methadone—Dizziness—Omeprazole—Barrett's esophagus	0.000594	0.00479	CcSEcCtD
Methadone—Dizziness—Esomeprazole—Barrett's esophagus	0.000594	0.00479	CcSEcCtD
Methadone—OPRK1—Mecp2 and Associated Rett Syndrome—SST—Barrett's esophagus	0.000583	0.0171	CbGpPWpGaD
Methadone—Vomiting—Omeprazole—Barrett's esophagus	0.000572	0.0046	CcSEcCtD
Methadone—Vomiting—Esomeprazole—Barrett's esophagus	0.000572	0.0046	CcSEcCtD
Methadone—Rash—Esomeprazole—Barrett's esophagus	0.000567	0.00456	CcSEcCtD
Methadone—Rash—Omeprazole—Barrett's esophagus	0.000567	0.00456	CcSEcCtD
Methadone—Dermatitis—Omeprazole—Barrett's esophagus	0.000566	0.00456	CcSEcCtD
Methadone—Dermatitis—Esomeprazole—Barrett's esophagus	0.000566	0.00456	CcSEcCtD
Methadone—Headache—Esomeprazole—Barrett's esophagus	0.000563	0.00453	CcSEcCtD
Methadone—Headache—Omeprazole—Barrett's esophagus	0.000563	0.00453	CcSEcCtD
Methadone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00055	0.0161	CbGpPWpGaD
Methadone—CYP3A7—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000542	0.0159	CbGpPWpGaD
Methadone—Nausea—Omeprazole—Barrett's esophagus	0.000534	0.0043	CcSEcCtD
Methadone—Nausea—Esomeprazole—Barrett's esophagus	0.000534	0.0043	CcSEcCtD
Methadone—CYP2C8—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000525	0.0154	CbGpPWpGaD
Methadone—CYP19A1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000513	0.015	CbGpPWpGaD
Methadone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000507	0.0149	CbGpPWpGaD
Methadone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000472	0.0138	CbGpPWpGaD
Methadone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000472	0.0138	CbGpPWpGaD
Methadone—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000469	0.0137	CbGpPWpGaD
Methadone—CYP3A7—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000446	0.0131	CbGpPWpGaD
Methadone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000441	0.0129	CbGpPWpGaD
Methadone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000441	0.0129	CbGpPWpGaD
Methadone—CYP3A5—Irinotecan Pathway—APC—Barrett's esophagus	0.000434	0.0127	CbGpPWpGaD
Methadone—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000428	0.0125	CbGpPWpGaD
Methadone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000406	0.0119	CbGpPWpGaD
Methadone—CYP2B6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000401	0.0118	CbGpPWpGaD
Methadone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000397	0.0116	CbGpPWpGaD
Methadone—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000392	0.0115	CbGpPWpGaD
Methadone—HTR3A—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000381	0.0112	CbGpPWpGaD
Methadone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000377	0.0111	CbGpPWpGaD
Methadone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000377	0.0111	CbGpPWpGaD
Methadone—CYP1A2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000365	0.0107	CbGpPWpGaD
Methadone—CYP2C18—Biological oxidations—CYP26A1—Barrett's esophagus	0.000356	0.0104	CbGpPWpGaD
Methadone—CYP2C18—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000351	0.0103	CbGpPWpGaD
Methadone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000344	0.0101	CbGpPWpGaD
Methadone—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00034	0.00996	CbGpPWpGaD
Methadone—CYP2B6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00033	0.00966	CbGpPWpGaD
Methadone—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000322	0.00944	CbGpPWpGaD
Methadone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000307	0.00901	CbGpPWpGaD
Methadone—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000304	0.0089	CbGpPWpGaD
Methadone—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000303	0.00889	CbGpPWpGaD
Methadone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000291	0.00853	CbGpPWpGaD
Methadone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000291	0.00853	CbGpPWpGaD
Methadone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000283	0.00828	CbGpPWpGaD
Methadone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00028	0.00821	CbGpPWpGaD
Methadone—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000279	0.00818	CbGpPWpGaD
Methadone—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000279	0.00817	CbGpPWpGaD
Methadone—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000276	0.0081	CbGpPWpGaD
Methadone—CYP19A1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000273	0.00799	CbGpPWpGaD
Methadone—CYP19A1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000269	0.00788	CbGpPWpGaD
Methadone—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000249	0.0073	CbGpPWpGaD
Methadone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000239	0.00702	CbGpPWpGaD
Methadone—CYP3A7—Biological oxidations—CYP26A1—Barrett's esophagus	0.000237	0.00694	CbGpPWpGaD
Methadone—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000236	0.00692	CbGpPWpGaD
Methadone—HTR3A—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000235	0.00688	CbGpPWpGaD
Methadone—CYP3A7—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000233	0.00684	CbGpPWpGaD
Methadone—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000229	0.00671	CbGpPWpGaD
Methadone—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000227	0.00666	CbGpPWpGaD
Methadone—OPRD1—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.000221	0.00648	CbGpPWpGaD
Methadone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000211	0.00618	CbGpPWpGaD
Methadone—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000202	0.00591	CbGpPWpGaD
Methadone—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000194	0.00569	CbGpPWpGaD
Methadone—OPRK1—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.000194	0.00568	CbGpPWpGaD
Methadone—OPRD1—G alpha (i) signalling events—SST—Barrett's esophagus	0.000186	0.00547	CbGpPWpGaD
Methadone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000185	0.00542	CbGpPWpGaD
Methadone—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000182	0.00534	CbGpPWpGaD
Methadone—CYP2B6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000175	0.00513	CbGpPWpGaD
Methadone—CYP2B6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000173	0.00506	CbGpPWpGaD
Methadone—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	0.000171	0.00502	CbGpPWpGaD
Methadone—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000169	0.00495	CbGpPWpGaD
Methadone—OPRM1—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.000164	0.0048	CbGpPWpGaD
Methadone—OPRK1—G alpha (i) signalling events—SST—Barrett's esophagus	0.000163	0.00479	CbGpPWpGaD
Methadone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000155	0.00456	CbGpPWpGaD
Methadone—Oxaprozin—PTGS2—Barrett's esophagus	0.000152	0.602	CrCbGaD
Methadone—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00015	0.00439	CbGpPWpGaD
Methadone—HTR3A—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000148	0.00435	CbGpPWpGaD
Methadone—OPRD1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000148	0.00435	CbGpPWpGaD
Methadone—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	0.000148	0.00434	CbGpPWpGaD
Methadone—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000146	0.00428	CbGpPWpGaD
Methadone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000145	0.00426	CbGpPWpGaD
Methadone—HTR3A—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000144	0.00422	CbGpPWpGaD
Methadone—OPRM1—G alpha (i) signalling events—SST—Barrett's esophagus	0.000138	0.00405	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000138	0.00405	CbGpPWpGaD
Methadone—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	0.000132	0.00388	CbGpPWpGaD
Methadone—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00013	0.00382	CbGpPWpGaD
Methadone—OPRK1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00013	0.00381	CbGpPWpGaD
Methadone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000124	0.00364	CbGpPWpGaD
Methadone—OPRM1—TCR Signaling Pathway—RELA—Barrett's esophagus	0.000123	0.00361	CbGpPWpGaD
Methadone—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000122	0.00357	CbGpPWpGaD
Methadone—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000121	0.00354	CbGpPWpGaD
Methadone—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00012	0.00352	CbGpPWpGaD
Methadone—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000119	0.00349	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—SST—Barrett's esophagus	0.000113	0.00331	CbGpPWpGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00011	0.00322	CbGpPWpGaD
Methadone—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000103	0.00302	CbGpPWpGaD
Methadone—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	0.000103	0.00302	CbGpPWpGaD
Methadone—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000102	0.00298	CbGpPWpGaD
Methadone—Phenylbutazone—PTGS2—Barrett's esophagus	0.0001	0.398	CrCbGaD
Methadone—OPRK1—GPCR ligand binding—SST—Barrett's esophagus	9.9e-05	0.0029	CbGpPWpGaD
Methadone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	9.57e-05	0.00281	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—GAST—Barrett's esophagus	9.31e-05	0.00273	CbGpPWpGaD
Methadone—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	9.2e-05	0.0027	CbGpPWpGaD
Methadone—OPRD1—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	8.61e-05	0.00252	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—GAST—Barrett's esophagus	8.45e-05	0.00248	CbGpPWpGaD
Methadone—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	8.39e-05	0.00246	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—SST—Barrett's esophagus	8.37e-05	0.00245	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—GAST—Barrett's esophagus	8.16e-05	0.00239	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PTGES—Barrett's esophagus	8.03e-05	0.00236	CbGpPWpGaD
Methadone—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	7.95e-05	0.00233	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	7.89e-05	0.00231	CbGpPWpGaD
Methadone—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	7.84e-05	0.0023	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	7.66e-05	0.00225	CbGpPWpGaD
Methadone—OPRK1—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	7.55e-05	0.00221	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.51e-05	0.0022	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—GAST—Barrett's esophagus	7.41e-05	0.00217	CbGpPWpGaD
Methadone—OPRD1—G alpha (i) signalling events—CXCL8—Barrett's esophagus	7.26e-05	0.00213	CbGpPWpGaD
Methadone—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	7.17e-05	0.0021	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—GAST—Barrett's esophagus	6.9e-05	0.00202	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.7e-05	0.00196	CbGpPWpGaD
Methadone—OPRM1—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	6.38e-05	0.00187	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—SST—Barrett's esophagus	6.38e-05	0.00187	CbGpPWpGaD
Methadone—OPRK1—G alpha (i) signalling events—CXCL8—Barrett's esophagus	6.37e-05	0.00187	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—GAST—Barrett's esophagus	6.26e-05	0.00184	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PTGES—Barrett's esophagus	6.15e-05	0.0018	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.11e-05	0.00179	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—CYP26A1—Barrett's esophagus	6.09e-05	0.00179	CbGpPWpGaD
Methadone—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	6.04e-05	0.00177	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—SST—Barrett's esophagus	5.79e-05	0.0017	CbGpPWpGaD
Methadone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.77e-05	0.00169	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—SST—Barrett's esophagus	5.59e-05	0.00164	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	5.54e-05	0.00163	CbGpPWpGaD
Methadone—OPRM1—G alpha (i) signalling events—CXCL8—Barrett's esophagus	5.38e-05	0.00158	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTGES—Barrett's esophagus	5.34e-05	0.00157	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	5.22e-05	0.00153	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—SST—Barrett's esophagus	5.08e-05	0.00149	CbGpPWpGaD
Methadone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.06e-05	0.00148	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—GAST—Barrett's esophagus	4.99e-05	0.00146	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—SST—Barrett's esophagus	4.73e-05	0.00139	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—CYP26A1—Barrett's esophagus	4.66e-05	0.00137	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	4.66e-05	0.00137	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—CXCL8—Barrett's esophagus	4.4e-05	0.00129	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—SLC9A1—Barrett's esophagus	4.39e-05	0.00129	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—GAST—Barrett's esophagus	4.38e-05	0.00128	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—SST—Barrett's esophagus	4.29e-05	0.00126	CbGpPWpGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.28e-05	0.00125	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	4.05e-05	0.00119	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—CYP26A1—Barrett's esophagus	4.05e-05	0.00119	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTGES—Barrett's esophagus	3.95e-05	0.00116	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTGES—Barrett's esophagus	3.86e-05	0.00113	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—CXCL8—Barrett's esophagus	3.86e-05	0.00113	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—GAST—Barrett's esophagus	3.7e-05	0.00108	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.44e-05	0.00101	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—SST—Barrett's esophagus	3.42e-05	0.001	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.4e-05	0.000996	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—SLC9A1—Barrett's esophagus	3.36e-05	0.000985	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTGES—Barrett's esophagus	3.34e-05	0.00098	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—CXCL8—Barrett's esophagus	3.26e-05	0.000955	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	3.07e-05	0.000901	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SST—Barrett's esophagus	3e-05	0.00088	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CYP26A1—Barrett's esophagus	2.99e-05	0.000878	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTGES—Barrett's esophagus	2.98e-05	0.000875	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	2.93e-05	0.000858	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—SLC9A1—Barrett's esophagus	2.92e-05	0.000855	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTGES—Barrett's esophagus	2.91e-05	0.000854	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTGES—Barrett's esophagus	2.75e-05	0.000805	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTGES—Barrett's esophagus	2.72e-05	0.000798	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.71e-05	0.000794	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SST—Barrett's esophagus	2.54e-05	0.000743	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	2.53e-05	0.000743	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.49e-05	0.000729	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTGES—Barrett's esophagus	2.33e-05	0.000682	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	2.26e-05	0.000663	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CXCL8—Barrett's esophagus	2.26e-05	0.000662	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	2.21e-05	0.000647	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.18e-05	0.000639	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—SLC9A1—Barrett's esophagus	2.16e-05	0.000633	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	2.11e-05	0.000618	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.08e-05	0.00061	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.06e-05	0.000605	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PPARG—Barrett's esophagus	2e-05	0.000587	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CXCL8—Barrett's esophagus	1.98e-05	0.00058	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.87e-05	0.000549	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.84e-05	0.00054	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	1.83e-05	0.000536	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	1.83e-05	0.000536	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—APC—Barrett's esophagus	1.81e-05	0.000531	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTGES—Barrett's esophagus	1.79e-05	0.000526	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	1.76e-05	0.000517	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CXCL8—Barrett's esophagus	1.67e-05	0.00049	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.67e-05	0.00049	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	1.63e-05	0.000478	CbGpPWpGaD
Methadone—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	1.59e-05	0.000467	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—APC—Barrett's esophagus	1.59e-05	0.000465	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PTGS2—Barrett's esophagus	1.58e-05	0.000462	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PPARG—Barrett's esophagus	1.53e-05	0.00045	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.52e-05	0.000447	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.5e-05	0.00044	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.49e-05	0.000436	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.47e-05	0.000432	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—RELA—Barrett's esophagus	1.41e-05	0.000415	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.36e-05	0.000399	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—APC—Barrett's esophagus	1.34e-05	0.000393	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CXCL8—Barrett's esophagus	1.33e-05	0.000391	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PPARG—Barrett's esophagus	1.33e-05	0.00039	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.31e-05	0.000385	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.3e-05	0.000382	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	1.27e-05	0.000372	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—RELA—Barrett's esophagus	1.24e-05	0.000364	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PTGS2—Barrett's esophagus	1.21e-05	0.000354	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.2e-05	0.000351	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CXCL8—Barrett's esophagus	1.17e-05	0.000343	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—RELA—Barrett's esophagus	1.05e-05	0.000307	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTGS2—Barrett's esophagus	1.05e-05	0.000307	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.02e-05	0.0003	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CXCL8—Barrett's esophagus	9.88e-06	0.00029	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PPARG—Barrett's esophagus	9.85e-06	0.000289	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	9.81e-06	0.000287	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PPARG—Barrett's esophagus	9.63e-06	0.000282	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PPARG—Barrett's esophagus	8.34e-06	0.000244	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TP53—Barrett's esophagus	8.18e-06	0.00024	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTGS2—Barrett's esophagus	7.75e-06	0.000227	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	7.57e-06	0.000222	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PPARG—Barrett's esophagus	7.44e-06	0.000218	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PPARG—Barrett's esophagus	7.27e-06	0.000213	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TP53—Barrett's esophagus	7.17e-06	0.00021	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PPARG—Barrett's esophagus	6.85e-06	0.000201	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PPARG—Barrett's esophagus	6.79e-06	0.000199	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	6.56e-06	0.000192	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TP53—Barrett's esophagus	6.06e-06	0.000178	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	5.86e-06	0.000172	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PPARG—Barrett's esophagus	5.8e-06	0.00017	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTGS2—Barrett's esophagus	5.72e-06	0.000168	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	5.39e-06	0.000158	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	5.34e-06	0.000157	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	4.56e-06	0.000134	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PPARG—Barrett's esophagus	4.48e-06	0.000131	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	3.52e-06	0.000103	CbGpPWpGaD
